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ABSTRACT
Objectives: The aim of the study was to assess the prevalence and severity of emotional problems among Polish women 
with polycystic ovary syndrome (PCOS) and seek factors which increase the risk of their occurrence.
Material and methods: The study group consisted of 82 women (aged 18–48), who were diagnosed with PCOS based 
on the Rotterdam criteria. During hospitalization, the patients completed a number of questionnaires, providing their 
sociodemographic data and information concerning the inconvenience of disease-associated symptoms. The question-
naires included the Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI), and Multidimensional Self-Esteem 
Inventory (MSEI). Data obtained during medical examinations (blood tests, transvaginal ultrasound, height and body mass 
measurements) were analyzed.
Results: Out of 82 women, the results detected risk for depression in 42 (51.22%), mild depressive disorders in 32, moderate 
disorders in 8, and severe disorder in 2 patients. No statistically significant correlation between BDI or state anxiety and 
the level of the analyzed hormones, insulin resistance, or infertility treatment, was found. General self-esteem, trait anxi-
ety, and marital status were associated with the occurrence of depression symptoms. BMI was associated with the level of 
state anxiety during hospitalization.
Conclusions: Women with PCOS are at risk for mood and anxiety disorders. Disease-related somatic factors are not directly 
associated with the risk for disorder occurrence. However, severity of depression symptoms has been shown to be influenced 
by permanent psychological characteristics of the studied women, i.e. self-esteem, trait anxiety, and life situation (marital 
status). Therefore, it is recommended to include interviews about patient life situation and screening questionnaires for 
assessing depression into the diagnostic procedures in PCOS patients. Patients should be referred for a psychological or 
psychiatric consultation, if needed.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is the most common 
endocrinopathy, affecting women in the reproductive age. 
PCOS is diagnosed in approximately 5–10% of the female 
population. The diagnostic criteria include hyperandro-
genism, ovulatory disorders, and the presence of ovar-
ian cysts on ultrasound. Diversity of the diagnostic criteria 
results in a significant patient heterogeneity in terms of 
concomitant symptoms such as hirsutism, acne, excess 
weight, or obesity. Due to its complex nature, PCOS may 
be accompanied by a number of problems, manifesting 
over the course of a patient’s life and causing consider-
able stress. PCOS is treated as a risk factor for infertility, 
metabolic syndrome, and cardiovascular diseases. Prospec-
tive studies in perimenopausal women with PCOS have 
demonstrated higher incidence of type II diabetes [1–5]. 
According to various authors, PCOS patients are more 
likely to suffer from mood disorders and increased anxi-
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ety [6–9]. Most studies on the mental functioning of the 
affected women are comparative, estimating the incidence 
of mood disorders and anxiety level in PCOS patients and 
healthy controls. The results unequivocally indicate that 
depressive disorders are 4–5 times more frequent among 
PCOS patients, and that the vast majority of the investi-
gated women present with mild or moderate symptoms of 
depression and slightly elevated anxiety levels. The main 
cause behind this remains unclear [10, 11], with androgen 
levels, hirsutism, obesity, insulin resistance, and infertility 
among the suggested reasons. Interestingly, obesity and 
infertility treatment, which have been identified as strong 
risk factors for depression in studies unrelated to PCOS, do 
not appear to differentiate the group of PCOS patients in 
terms of risk for mood disorders, according to preliminary 
reports [12]. A recent study conducted on a relatively large 
sample of women (n = 301) has reported the suspected role 
of insulin resistance as a risk factor for depression in PCOS 
patients. However, the results are not consistent with pre-
vious publications [13]. Reports evaluating the influence 
of the body mass index (BMI) on the risk for depression 
also present conflicting results [14, 15]. Several studies on 
the quality of life in PCOS patients have been published. 
Their results led us to believe that factors influencing the 
risk for mood disturbance and anxiety in the context of 
PCOS symptoms may include patient resources, i.e. in-
ternal mental disposition as well as environmental sup-
port [16, 17]. Concurrent analysis of the relevant medical 
and psychological factors and an attempt to describe the 
mechanisms of developing mood and anxiety disorders in 
PCOS patients, rather than attempting to identify a single 
factor, appears to be a promising method.
OBJECTIVES
The primary aim of the study was to investigate the 
prevalence and severity of emotional problems (i.e., symp-
toms of mood disorders and anxiety levels during hospitali-
zation) in Polish women with PCOS. The secondary aim was 
to explore the promoting factors. Based on the review of the 
literature, these factors were assumed to include biochemi-
cal variables reflecting the status of the somatic disease [BMI, 
insulin resistance, infertility, levels of testosterone, prolactin, 
sex hormone binding globulin (SHBG), didehydroepian-
drosterone (DHEAS), cortisol] and psychological variables: 
subjective perception of the disease, self-esteem, and life 
situation (intimate relationship, children).
MATERIAL AND METHODS
Material
This was a cross-sectional study of PCOS women (n = 82), 
aged 18–48 (mean = 28, SD = 5.48), diagnosed using the 
Rotterdam criteria, who were examined between 2012 and 
2015 during hospitalization at the Division of Infertility and 
Reproductive Endocrinology, Department of Obstetrics and 
Gynecology, Poznan University of Medical Sciences. Written 
informed consent was obtained and the patients completed 
the questionnaires. The research presented here is a part of 
a larger study.
Measures
Somatic state: data were obtained during medical 
examination including body mass and height measure-
ments, ovarian ultrasound, and blood tests. The analysis 
of endocrine markers included the following parameters: 
testosterone (ng/mL), DHEAS (μmol/L), prolactin (ng/ml), 
SHBG (nmol/L), and morning cortisol (nmol/L). Insulin resis-
tance was diagnosed using oral glucose tolerance tests. The 
patients were also asked whether they were undergoing 
infertility treatment.
Subjective experience of the disorder: A questionnaire 
concerning the inconvenience of particular PCOS symptoms 
was used. The symptoms included obesity, hirsutism, infer-
tility, irregular menstrual periods/amenorrhea, acne, sebor-
rhea, alopecia, dark spots on the skin, pelvic pain, strong pre-
menstrual syndrome (PMS). With regard to specific spheres 
of functioning (professional life, sexuality, social contacts, 
physical and mental well-being), the patients were asked 
which symptoms they perceived as the most inconvenient.
Sociodemographic status: The questionnaire included 
questions about the following sociodemographic data: 
age, education, place of residence, intimate relationship, 
duration of the relationship, cohabitation, marital status, 
children.
Emotional problems: Two measures of emotional 
disturbances were used: the Beck Depression Inventory 
(BDI; Beck, 1961; Polish adaptation by Parnowski, Jer-
najczyk, 1977), and the State-Trait Anxiety Inventory 
(STAI; Spielberger et al., 1970; Polish adaptation by Spiel-
berger, Wrześniewski et al. 1987) [18, 19].
Self-esteem was evaluated with the Multidimensional 
Self-Esteem Inventory (MSEI; O’Brien, Epstein, 1988; Polish 
adaptation by Zawadzki, Strelau et al., 2007) [20].
Statistical analysis
Descriptive data were evaluated using means (M), stan-
dard deviations (SD), ranges, and frequencies. Pearson and 
Spearman correlation coefficients and partial correlation 
coefficients as well as multiple regression analysis were 
used to verify the relationships between the intensity of 
emotional problems and other variables in the sample. 
Student’s t test was used to compare the continuous vari-
ables among the groups. P-value of < 0.05 was considered 
as statistically significant. The calculations were performed 
using IBM Statistics SPSS, version 23.0.
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RESULTS
Sociodemographic characteristics  
and clinical symptoms in the sample
Patient age was 18–48 years (mean = 28 years, 
SD = 5.48 years). The majority of the women had second-
ary or higher education (n = 77, 93.9%), were in a stable and 
intimate relationship (n = 73, 89%), lived together with their 
partners (n = 59, 72%), and were married (n = 44, 53.7%). 
Only 15 (18.3%) of the women had children. Detailed char-
acteristics of the sample are presented in Table 1.
Prevalence of depression and anxiety  
in the sample
Mean BDI score in the sample was 11.17 (SD = 7.65, range 
0–40). Forty (48.8%) patients had low BDI scores, indicating 
lack of depressive symptoms, 32 (39%) — mild depression, 
8 (9.76%) — moderate (11–27 points), and 2 (2.44%) had 
high scores, indicating severe depression1. Mean STAI score 
was 42.88, (SD = 10.35, range 21–69), which corresponded 
to the STen score of 7, according to the norms described for 
the Polish population. 
Correlations of depression and anxiety  
in the sample
Biochemical indicators were not related to depression 
or state anxiety in the sample (Table 2). The only signifi-
cant relationship was detected between state anxiety and 
BMI. Neither depression (t = –0.197, df = 80, p = 0.844) nor 
anxiety (t = 0.554, df = 64,483, p = 0.581) were related to 
insulin resistance. Similar findings were revealed for infertil-
ity treatment: no differences between the groups in terms 
of depression were found (t = 0.079, df = 80, p = 0.937) or 
anxiety (t = –0.318, df = 45.453, p = 0.752).
The patients reported various levels of inconvenience 
associated with specific PCOS symptoms in their daily 
lives. The analysis included only those symptoms which 
were reported by at least 25% of the studied women. There-
fore, data concerning alopecia, seborrhea, pelvic pain, and 
dark skin spots were not analyzed due to low incidence of 
these symptoms. Detailed analysis revealed no differences 
between the level of depression and the reported level of 
inconvenience associated with obesity, hirsutism, infertility, 
irregular periods, acne, and prolonged PMS. Higher levels 
of state anxiety were declared by patients who reported 
the inconvenience of obesity in their lives. Patients who 
reported the inconvenience of menstrual disturbances and 
acne declared lower state anxiety (Table 3). There were no 
1 The interpretation of BDI stores was made on the basis of the follow-
ing intervals: ≤ 9 points — lack of depressive symptoms, 10–18 points 
— mild depression, 19–29 points — moderate depression, > 30 points 
— severe depression [21]
Table 1. Sociodemographic and clinical characteristics of the studied 
PCOS patients (n = 82)
Sociodemographic
Age (years)* 28 ± 5.48
Education**
Primary: 2 (2.44%)
Occupational: 3 (3.66%)
Secondary: 28 (34.15%)
Higher: 49 (59.75%)
Place of residence**
Village: 24 (29.3%)
Town > 10 000: 7 (8.5%)
Town 10 000–100 000: 16 (19.5%)
City 100 000–500 000: 4 (4.9%)
City < 500 000: 31 (37.8%)
Relationship status (stable 
and intimate relationship)**
No: 9 (11%)
Yes:
> 6 months: 3 (3.7%)
6 months–1 year: 8 (9.8%)
1–5 years: 17 (20.7%)
5–10 years: 34 (41.5%)
< 10 years: 11 (13.4%)
Cohabitation** No: 23 (28%)Yes: 59 (72%)
Marital status**
Single: 37 (45.1%)
Divorced: 1 (1.2%)
Married: 44 (53.7%)
Children** No: 67 (81.7%)Yes: 15 (18.3%)
Clinical
Testosterone [ng/mL]* 0.47 ± 0.16 
Prolactin [ng/ml]* 27.45 ± 19.22
SHBG [nmol/L]* 55.20 ± 42.29
DHEAS [umol/L]* 8.03 ± 3.38
Cortisol 8.00 [nmol/L]* 507.71 ± 178.95
BMI* 26.0 ± 5.30
Insulin resistance** Yes: 43 (52.44%)No: 39 (47.56%)
Infertility treatment** Yes: 56 (68.3%)No: 26 (31.7%)
*Mean ± SD; **number (percent)
Table 2. Relationships between emotional problems and somatic 
state in the sample (partial correlation coefficients)
Depression Anxiety
Testosterone 0.035 (n.s.) –0.069 (n.s.)
Prolactin –0.196 (n.s.) –0.035 (n.s.)
SHBG –0.094 (n.s.) –0.065 (n.s.)
DHEAS –0.116 (n.s.) –0.040 (n.s.)
Cortisol 8.00 –0.013 (n.s.) 0.128 (n.s.)
BMI 0.154 (n.s.) 0.361 (p = 0.008)
n.s. — not statistically significant
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differences between the groups with regard to hirsutism, 
infertility, and prolonged PMS.
Data were checked for correlations between intensity 
of the emotional problems and the sociodemographic 
characteristics of the studied patients. The obtained re-
sults showed no significant association between depression 
and the investigated characteristics: age (r = 0.005, n.s.), 
education (rs = –0.164, n.s.), place of residence (rs = –0.115, 
n.s.), intimate relationship and its duration (rs = 0.029, n.s.), 
cohabitation (t = –0.143, df = 80, n.s.), and having children 
(t = –0.043, df = 80, n.s.). Similarly, the reported level of anxi-
ety was not associated with age (r = 0.183, n.s.), education 
(rs = 0.03, n.s.), place of residence (rs = –0.094, n.s.), intimate 
relationship and its duration (rs = –0.016, n.s.), cohabitation 
(t = 0.762, df = 80, n.s.), marital status (t = –1,773, df = 80, 
n.s.), or having children (t = –0.974, df = 80, n.s.).
A statistically significant negative correlation between 
self-esteem and depression (r = –0.732; p < 0.001) and state 
anxiety (r = –0.511, p < 0.001) was found. A strong positive 
relationship was also found between depression and anxiety 
including both, state anxiety (r = 0.554, p < 0.001) and trait 
anxiety (r = 0.736, p < 0.001).
Correlations between depression level and the rela-
tively permanent characteristics of the studied patients 
(self-esteem, trait anxiety), as well as a near-significant as-
sociation with marital status, prompted us to perform mul-
tiple regression analysis. The significance of two out of the 
three investigated predictors of depression (self-esteem and 
marital status) is presented in Figure 1.
Analysis of the significance of self-esteem and marital 
status as predictors of depression in PCOS patients indicated 
that the model was statistically significant [F(2) = 46.128, 
p < 0.001] and that both predictors explained a total of 
56% of depression level variability. The introduction of the 
individual disposition to react with anxiety (trait anxiety) as 
another predictor resulted in a statistically significant 15% 
increase in model significance [F(2,67) = 15.67, p < 0.001].
The model including these three predictors had strong 
goodness-of-fit [F(3) = 46.918, p < 0.001] explained 66% of 
the variance changes in the level of depression. The values 
Table 3. Declared inconvenience of PCOS symptoms and anxiety in the sample
Symptom Inconvenience of the symptom Mean ± SD Group differences statistics
Obesity
Yes 46.06 ± 9.54
t = 3.865, df = 80, p < 0.001
No 37.58 ± 9.68
Irregular menstrual periods/amenorrhea
Yes 39.57 ± 9.52
t = –2.675, df = 80, p = 0.009
No 45.55 ± 10.42
Acne
Yes 38.55 ± 10.27
t = –2.317, df = 80, p = 0.023
No 44.41 ± 10.07
30
20
10
0
D
ep
re
ss
io
n 
(B
D
I s
co
re
)
Self-esteem (MSEI score)
Single
Married
y = 38.31 – 0.89x
y = 25.4 – 0.54x
2010 30 40 50
Figure 1. Self-esteem and marital status as predictors of depression 
in the sample
of standardized beta coefficients for the individual predic-
tors were as follows: self-esteem: β = –0.471, p < 0.001, 
trait anxiety: β = 0.413, p < 0.001, marital status: β = 0.159, 
p = 0.026.
The level of state anxiety declared by the patients was as-
sociated with several other groups of variables: BMI, reported 
inconvenience of PCOS symptoms (obesity, irregular periods, 
and acne), as well as self-esteem and relatively permanent 
disposition to react with anxiety (trait anxiety). The results of 
hierarchical regression analysis conducted for the individual 
predictors of state anxiety are presented in Table 4. Their 
comparison led to the conclusion that the strongest predictor, 
out of the ones included in the individual models, was a per-
manent disposition of a patient to react with anxiety (Model 
4). Trait anxiety enabled to predict 70% of the variability in the 
results of patient-reported anxiety; the result abolished the 
significance of all other previously considered predictors, in-
cluding self-esteem and the inconvenient disease symptoms.
DISCUSSION
The emotional state of women undergoing PCOS treat-
ment is important due to its influence on patient motivation, 
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treatment compliance, the risk of secondary development 
of mental disorders, and the overall life satisfaction. It also 
affects e.g., interest in sexual activity, thus influencing the 
effectiveness of infertility treatment [12, 17].
Higher manifestation of depression symptoms in PCOS 
patients in the Polish population, demonstrated in the pre-
sent study, is relatively pronounced, while remaining similar 
to the results obtained in other countries [10]. This justifies 
the use of short screening questionnaires assessing the risk 
for mood disorders in PCOS patients. In case of results which 
cause concern, the patient can be referred for a psychiatric 
or psychological consultation.
Noteworthy, increased BMI and inconvenience of obe-
sity was more often reported among women who declared 
elevated anxiety levels during the evaluation (including 
hospital stay). In this context, it is interesting to find no re-
lationship between the severity of depression symptoms or 
anxiety levels and insulin resistance of the studied women 
(despite the fact that insulin resistance is largely responsible 
for obesity problems among PCOS women) [1]. The fact 
that patients with elevated BMI reacted to the study with 
anxiety and were more likely to report the inconvenience 
of this symptom can be interpreted as an effect of impaired 
neuroendocrine balance and metabolic dysregulation. On 
the other hand, it can also be understood as a consequence 
of social exposition during hospitalization and a sense of 
non-compliance to dietary recommendations or to a broad-
er social requirement to have a slim, athletic body build. The 
results obtained in this context require further exploration, 
especially that the observed relationships were largely bur-
dened with a masking influence of individual disposition 
to react with anxiety. The significance of this issue appears 
important insofar as its analysis may help identify the factors 
which intensify the unfavorable emotional condition of a pa-
tient during hospitalization in order to employ appropriate 
diagnostic cooperation and treatment.
None of the studied endocrine factors were associated 
with increased depression symptoms or anxiety levels. Pre-
vious publications also failed to demonstrate a correlation 
between androgen levels and emotional functioning of 
the affected patients. However, no relationship with the 
level of cortisol measured after a night’s rest was found in 
our study group. There is a great amount of evidence for 
the influence of elevated cortisol levels and the associated 
functioning of the hypothalamic–pituitary–adrenal axis on 
the occurrence of depression symptoms [22]. Since high 
blood cortisol levels are strongly associated with the acute 
phase of depression, it can be surmised that PCOS patients 
are more likely to suffer from dysthymic disorders.
The significance of a permanent disposition to react 
with anxiety, low self-esteem, and being married in terms of 
increased risk of developing depression symptoms indicates 
the need for introducing psychological diagnostics and 
evaluation of individual characteristics and life situation in 
PCOS patients. The obtained results may indicate that the 
reasons behind mood disorders and increased anxiety levels 
are associated more with specific psychological disposi-
tion of women affected by a chronic disease and universal 
stress generated by the inconvenient symptoms and their 
consequences than with biochemical factors typical for 
PCOS. The obtained results yet again provoke reflection 
on the limitations of linear (cause-effect) explanations for 
Table 4. Multiple regression analysis of predictors of state anxiety in the sample
Significance 
of the model Adjusted R square
Change of significance 
of a model statistics Predictors*
Model 1 F(3) = 5.47; p = 0.002 0.169
Obesity β = 0.316; p = 0.010
Acne β = –0.187; n.s.
Irregular periods β = –0.143; n.s. 
Model 2 F(4) = 4.61; p = 0.003 0.180 F(1, 62) = 1.81; p = 0.183
Obesity β = 0.252; n.s
Acne β = –0.117; n.s.
Irregular periods β = –0.188; n.s.
BMI β = 0.167; n.s.
Model 3 F(5) = 8.89; p = 0.001 0.374 F(1, 61) = 20.29; p = 0.001 
Obesity β = 0.174; n.s.
Acne β = –0.132; n.s.
Irregular periods β = –0.077; n.s.
BMI β = 0.153; n.s.
Self-esteem β = –0.457; p < 0.001
Model 4 F(6) = 26.65; p = 0.001 0.700 F(1, 60) = 67,18; p = 0.001
Obesity β = 0.114; n.s.
Acne β = –0.094; n.s.
Menstrual disorders β = –0.031; n.s.
BMI β = 0.086; n.s.
Self-esteem β = –0.059; n.s.
Trat anxiety β = 0.716; p < 0.001
*β — standardized beta coefficient
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mental disorders. The abolishment of the discriminatory 
value of such factors as infertility treatment, cortisol levels, 
and the inconvenience of hirsutism or acne indicates that 
the development of depression or anxiety in a group as 
heterogeneous as PCOS patients can be influenced by nu-
merous factors, the significance of which can be mutually 
strengthened or abolished. Individual contact, together with 
the resulting personalized and interdisciplinary diagnosis, 
seem to offer a chance of identifying patient-specific groups 
of risk factors for secondary mood disorders associated with 
PCOS. In turn, this can contribute to selection of the optimal 
treatment method and improve patient compliance with 
recommendations.
One limitation of the presented study is the structure 
of the study group in terms of education and severity of 
depression symptoms. The vast majority of the investigated 
women had higher education, and few of them had severe 
depression symptoms, which means that the results can only 
be used for similar patient groups. The above suggests that 
more research on the subject should be conducted among 
women with lower education and more severe emotional 
problems.
CONCLUSIONS
Women with PCOS are susceptible to mood and anxiety 
disorders. Hyperinsulinemia, hyperandrogenism, levels of 
cortisol, prolactin, SHGB, and DHEAS, as well as infertility 
treatment were found to be not associated with depres-
sion symptoms and anxiety levels in PCOS patients. Factors 
including low general self-esteem, intensified permanent 
tendency to react with anxiety, and being in a formal rela-
tionship are associated with worse emotional functioning 
and higher risk for depression. The results indicate the com-
plexity of the factors associated with depression in these 
women, justifying the need to screen for depression and to 
refer patients for psychological or psychiatric consultations 
if the results are a cause for concern.
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